Jaguar Animal Health Stock EBITDA

JAGX Stock

USD 4.40 0.22 4.76%

By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Jaguar Animal's long-term financial health and intrinsic value.

		Last Reported	Projected for Next Year
	EBITDA	-36.7 M	-38.5 M

EBITDA is likely to drop to about (38.5 M) in 2025.

Build AI portfolio with Jaguar Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Jaguar Animal Health Company EBITDA Analysis

Jaguar Animal's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Jaguar Animal EBITDA

(36.66 M)

Most of Jaguar Animal's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jaguar Animal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Jaguar EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Jaguar Animal is extremely important. It helps to project a fair market value of Jaguar Stock properly, considering its historical fundamentals such as EBITDA. Since Jaguar Animal's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Jaguar Animal's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Jaguar Animal's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Net Debt	Current Deferred Revenue	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.68	-0.53	-0.82	0.93	0.77	0.5	-0.83	0.96	0.68	0.77	0.7	0.89	0.85	0.66	0.79	0.49	0.67	0.88	0.11	0.64	0.11
Total Stockholder Equity	0.68		-0.43	-0.33	0.7	0.37	0.46	-0.56	0.47	0.17	0.34	0.17	0.76	0.75	0.14	0.26	0.55	0.45	0.52	-0.06	0.42	0.24
Net Tangible Assets	-0.53	-0.43		0.27	-0.64	-0.3	-0.18	0.48	-0.5	-0.49	-0.16	-0.48	-0.71	-0.54	-0.35	-0.5	-0.23	-0.33	-0.34	0.06	-0.1	0.07
Retained Earnings	-0.82	-0.33	0.27		-0.67	-0.84	-0.49	0.71	-0.87	-0.58	-0.97	-0.6	-0.59	-0.61	-0.72	-0.92	-0.17	-0.8	-0.96	-0.37	-0.85	-0.01
Accounts Payable	0.93	0.7	-0.64	-0.67		0.57	0.37	-0.81	0.86	0.69	0.58	0.7	0.95	0.92	0.47	0.71	0.41	0.54	0.74	-0.09	0.42	0.21
Long Term Debt	0.77	0.37	-0.3	-0.84	0.57		0.46	-0.56	0.8	0.31	0.84	0.34	0.47	0.54	0.88	0.8	0.18	0.86	0.78	0.65	0.85	-0.24
Net Receivables	0.5	0.46	-0.18	-0.49	0.37	0.46		-0.41	0.46	0.22	0.48	0.23	0.43	0.5	0.22	0.34	0.46	0.53	0.66	0.09	0.53	0.06
Short Term Investments	-0.83	-0.56	0.48	0.71	-0.81	-0.56	-0.41		-0.81	-0.64	-0.61	-0.65	-0.83	-0.75	-0.47	-0.71	-0.44	-0.49	-0.78	0.04	-0.51	-0.2
Total Liab	0.96	0.47	-0.5	-0.87	0.86	0.8	0.46	-0.81		0.77	0.81	0.79	0.81	0.74	0.76	0.86	0.39	0.66	0.88	0.16	0.62	0.05
Short Long Term Debt	0.68	0.17	-0.49	-0.58	0.69	0.31	0.22	-0.64	0.77		0.46	1.0	0.69	0.56	0.43	0.69	0.22	0.27	0.59	-0.23	0.11	0.08
Total Current Assets	0.77	0.34	-0.16	-0.97	0.58	0.84	0.48	-0.61	0.81	0.46		0.48	0.5	0.54	0.69	0.83	0.25	0.82	0.92	0.46	0.9	-0.08
Short Term Debt	0.7	0.17	-0.48	-0.6	0.7	0.34	0.23	-0.65	0.79	1.0	0.48		0.7	0.57	0.46	0.7	0.23	0.28	0.6	-0.21	0.13	0.09
Intangible Assets	0.89	0.76	-0.71	-0.59	0.95	0.47	0.43	-0.83	0.81	0.69	0.5	0.7		0.86	0.36	0.64	0.53	0.45	0.72	-0.23	0.36	0.25
Common Stock	0.85	0.75	-0.54	-0.61	0.92	0.54	0.5	-0.75	0.74	0.56	0.54	0.57	0.86		0.35	0.64	0.35	0.61	0.7	0.03	0.43	0.06
Property Plant Equipment	0.66	0.14	-0.35	-0.72	0.47	0.88	0.22	-0.47	0.76	0.43	0.69	0.46	0.36	0.35		0.75	0.02	0.71	0.62	0.61	0.63	-0.23
Net Debt	0.79	0.26	-0.5	-0.92	0.71	0.8	0.34	-0.71	0.86	0.69	0.83	0.7	0.64	0.64	0.75		0.0	0.78	0.84	0.36	0.66	-0.15
Current Deferred Revenue	0.49	0.55	-0.23	-0.17	0.41	0.18	0.46	-0.44	0.39	0.22	0.25	0.23	0.53	0.35	0.02	0.0		0.04	0.37	-0.26	0.23	0.19
Long Term Debt Total	0.67	0.45	-0.33	-0.8	0.54	0.86	0.53	-0.49	0.66	0.27	0.82	0.28	0.45	0.61	0.71	0.78	0.04		0.78	0.68	0.81	-0.35
Capital Surpluse	0.88	0.52	-0.34	-0.96	0.74	0.78	0.66	-0.78	0.88	0.59	0.92	0.6	0.72	0.7	0.62	0.84	0.37	0.78		0.22	0.83	0.12
Net Invested Capital	0.11	-0.06	0.06	-0.37	-0.09	0.65	0.09	0.04	0.16	-0.23	0.46	-0.21	-0.23	0.03	0.61	0.36	-0.26	0.68	0.22		0.57	-0.71
Net Working Capital	0.64	0.42	-0.1	-0.85	0.42	0.85	0.53	-0.51	0.62	0.11	0.9	0.13	0.36	0.43	0.63	0.66	0.23	0.81	0.83	0.57		-0.04
Capital Stock	0.11	0.24	0.07	-0.01	0.21	-0.24	0.06	-0.2	0.05	0.08	-0.08	0.09	0.25	0.06	-0.23	-0.15	0.19	-0.35	0.12	-0.71	-0.04

Click cells to compare fundamentals

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Jaguar Animal

Ebitda Over Time

Jaguar Ebitda

Ebitda

(38.5 Million)

Jaguar Animal reported EBITDA of (36.66 Million) in 2024

According to the company disclosure, Jaguar Animal Health reported earnings before interest,tax, depreciation and amortization of (36.66 Million). This is 104.18% lower than that of the Pharmaceuticals sector and 136.6% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.94% higher than that of the company.

Jaguar EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jaguar Animal's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jaguar Animal could also be used in its relative valuation, which is a method of valuing Jaguar Animal by comparing valuation metrics of similar companies.

Jaguar Animal is currently under evaluation in ebitda category among its peers.

Jaguar Animal Current Valuation Drivers

We derive many important indicators used in calculating different scores of Jaguar Animal from analyzing Jaguar Animal's financial statements. These drivers represent accounts that assess Jaguar Animal's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Jaguar Animal's important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	46.8K	207.0K	38.1K	1.2M	7.4M	7.8M
Enterprise Value	4.1M	8.2M	29.4M	31.8M	36.0M	37.8M

Jaguar Animal ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Jaguar Animal's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Jaguar Animal's managers, analysts, and investors.

Environmental

Governance

Social

Jaguar Animal Institutional Holders

Institutional Holdings refers to the ownership stake in Jaguar Animal that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Jaguar Animal's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Jaguar Animal's value.

		Shares
Commonwealth Equity Services Inc	2024-12-31	0.0
Northern Trust Investments N A	2024-12-31	0.0
Vanguard Group Inc	2025-03-31	0.0
Geode Capital Management, Llc	2025-03-31	0.0
Virtu Financial Llc	2025-03-31	0.0
Two Sigma Securities, Llc	2024-12-31	0.0
Hrt Financial Llc	2025-03-31	0.0
Ubs Group Ag	2024-12-31	50.7 K
Susquehanna International Group, Llp	2024-12-31	11.5 K
Royal Bank Of Canada	2025-03-31	702
Sbi Securities Co Ltd	2025-03-31	20.0

Jaguar Fundamentals

	Return On Equity	-4.6
	Return On Asset	-0.37
	Operating Margin	(4.26) %
	Current Valuation	38.12 M
	Shares Outstanding	1.26 M
	Shares Owned By Insiders	10.17 %
	Shares Owned By Institutions	6.89 %
	Number Of Shares Shorted	32.26 K
	Price To Earning	(0.96) X
	Price To Book	3.07 X
	Price To Sales	0.48 X
	Revenue	11.69 M
	Gross Profit	9.51 M
	EBITDA	(36.66 M)
	Net Income	(39.03 M)
	Cash And Equivalents	9.01 M
	Cash Per Share	0.08 X
	Total Debt	36.53 M
	Current Ratio	1.02 X
	Book Value Per Share	2.64 X
	Cash Flow From Operations	(29.38 M)
	Short Ratio	0.14 X
	Earnings Per Share	(60.27) X
	Price To Earnings To Growth	(0.02) X
	Target Price	38.0
	Number Of Employees	49
	Beta	0.96
	Market Capitalization	5.56 M
	Total Asset	53.42 M
	Retained Earnings	(346.48 M)
	Working Capital	12.49 M
	Current Asset	8.45 M
	Current Liabilities	3.91 M
	Net Asset	53.42 M

About Jaguar Animal Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Jaguar Animal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jaguar Animal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jaguar Animal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

IGIB	iShares 5 10 Year
SPTL	SPDR Barclays Long
SCHH	Schwab REIT ETF

Additional Tools for Jaguar Stock Analysis

When running Jaguar Animal's price analysis, check to measure Jaguar Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jaguar Animal is operating at the current time. Most of Jaguar Animal's value examination focuses on studying past and present price action to predict the probability of Jaguar Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jaguar Animal's price. Additionally, you may evaluate how the addition of Jaguar Animal to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC